Jay Yang

3.3k citations

103 papers · 1.3k indexed · h-index 18

Impact in

Hematology top 5%
- Acute Myeloid Leukemia Research
Molecular Biology top 10%
- DNA Repair Mechanisms
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
- Epigenetics and DNA Methylation
- Cancer therapeutics and mechanisms
- Ubiquitin and proteasome pathways

Papers in ⓘ

Hematology 46
- Acute Myeloid Leukemia Research 35
- Chronic Myeloid Leukemia Treatments 16
Genetics 20
- Myeloproliferative Neoplasms: Diagnosis and Treatment 13

Co-authors: Grant W. Brown (8 shared papers)Ian D. Hickson (3 shared papers)Csanád Z. Bachrati (3 shared papers)Yongwei Su (7 shared papers)Yubin Ge (7 shared papers)Holly Edwards (7 shared papers)Jeffrey W. Taub (7 shared papers)Alexandra Sobeck (1 shared paper)
Journals: Blood (35 papers)Journal of Clinical Oncology (10 papers)Hematological Oncology (3 papers)Journal of Pain (3 papers)Haematologica (2 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

Jay Yang

92 papers receiving 1.3k citations

Peers

Countries citing papers authored by Jay Yang

Since Specialization

Citations

This map shows the geographic impact of Jay Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay Yang more than expected).

Fields of papers citing papers by Jay Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay Yang. The network helps show where Jay Yang may publish in the future.

Co-authors

The 25 scholars most cited alongside Jay Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jay Yang Line = papers co-authored together Jay Yang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	RMI, a new OB-fold complex essential for Bloom syndrome protein to maintain genome stability Genes & Development ·Dongyi Xu, Rong Guo, Alexandra Sobeck, Csanád Z. Bachrati, Jay Yang, Takemi Enomoto, Grant W. Brown, Maureen E. Hoatlin, Ian D. Hickson, Weidong Wang	2008	165
2	Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy Signal Transduction and Targeted Therapy ·Jenna L. Carter, Katie Hege, Jay Yang, Hasini A. Kalpage, Yongwei Su, Holly Edwards, Maik Hüttemann, Jeffrey W. Taub, Yubin Ge	2020	143
3	IMRT of large fields: whole-abdomen irradiation International Journal of Radiation OncologyBiologyPhysics ·Linda Hong, Kaled M. Alektiar, Chen S. Chui, Tom LoSasso, Margie Hunt, Spiridon V. Spirou, Jay Yang, Howard Amols, Clifton C. Ling, Zvi Fuks, Steve Leibel	2002	86
4	EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: a multicentre, open-label, phase 2 study The Lancet Oncology ·Marjorie G. Zauderer, Peter W. Szlosarek, Sylvestre Le Moulec, Sanjay Popat, Paul Taylor, David Planchard, Arnaud Scherpereel, Marianna Koczywas, Martin Förster, Robert B. Cameron, Tobias Peikert, Evren Kocabaş Argon, Neil R. Michaud, Attila Szántó, Jay Yang, Yingxue Chen, Vikram Kansra, Shefali Agarwal, Dean A. Fennell	2022	85
5	Suppression of genomic instability by SLX5 and SLX8 in Saccharomyces cerevisiae DNA repair ·Chaoying Zhang, Tania Michelle Roberts, Jay Yang, Ridhdhi Desai, Grant W. Brown	2005	78
6	Human Topoisomerase IIIα Is a Single-stranded DNA Decatenase That Is Stimulated by BLM and RMI1 Journal of Biological Chemistry ·Jay Yang, Csanád Z. Bachrati, Jiongwen Ou, Ian D. Hickson, Grant W. Brown	2010	57
7	Antileukemic activity and mechanism of action of the novel PI3K and histone deacetylase dual inhibitor CUDC-907 in acute myeloid leukemia Haematologica ·Xinyu Li, Yongwei Su, Gerard J. Madlambayan, Holly Edwards, Lisa Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Jun Ma, Tristan Knight, Guan Wang, Yue Wang, Jay Yang, Jeffrey W. Taub, Hai Lin, Yubin Ge	2019	56
8	Safety and efficacy of tazemetostat, a first-in-class EZH2 inhibitor, in patients (pts) with epithelioid sarcoma (ES) (NCT02601950). Journal of Clinical Oncology ·Silvia Stacchiotti, Patrick Schöffski, Robin L. Jones, Mark Agulnik, Víctor M. Villalobos, Thierry Jahan, Tom Wei‐Wu Chen, Antoîne Italiano, George D. Demetri, Gregory M. Coté, Rashmi Chugh, Steven Attia, Abha A. Gupta, Elizabeth T. Loggers, Brian A. Van Tine, Laura Sierra, Jay Yang, Anand Rajarethinam, Mrinal M. Gounder	2019	48
9	The HDAC and PI3K dual inhibitor CUDC-907 synergistically enhances the antileukemic activity of venetoclax in preclinical models of acute myeloid leukemia Haematologica ·Xinyu Li, Yongwei Su, Katie Hege, Gerard J. Madlambayan, Holly Edwards, Tristan Knight, Lisa Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Jay Yang, Regan Miller, Guan Wang, Lijing Zhao, Y. Lynn Wang, Hai Lin, Jeffrey W. Taub, Yubin Ge	2020	38
10	Eribulin Monotherapy in Patients Aged 70 Years and Older With Metastatic Breast Cancer The Oncologist ·Hyman B. Muss, Javier Cortés, Linda T. Vahdat, Fátima Cardoso, Chris Twelves, J. Wanders, Corina E. Dutcus, Jay Yang, Seth Seegobin, Joyce O’Shaughnessy	2014	35
11	An Open-label, Phase II Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Diffuse Large B-cell Lymphoma Clinical Lymphoma Myeloma & Leukemia ·John M. Burke, Andrei R. Shustov, James Essell, Dipti Patel‐Donnelly, Jay Yang, Robert Chen, Wei Ye, Wen Shi, Sarit Assouline, Jeff P. Sharman	2018	30
12	RMI1 Promotes DNA Replication Fork Progression and Recovery from Replication Fork Stress Molecular and Cellular Biology ·Jay Yang, Lara O’Donnell, Daniel Durocher, Grant W. Brown	2012	27
13	Secondary Primary Malignancies in Multiple Myeloma: An Old Nemesis Revisited Advances in Hematology ·Jay Yang, Howard R. Terebelo, Jeffrey A. Zonder	2012	26
14	Omega-3/Omega-6 Long-Chain Fatty Acid Imbalance in Phase I Retinopathy of Prematurity Nutrients ·Zhongjie Fu, Wenjun Yan, Chuck T. Chen, Anders Nilsson, Edward Bull, William E. Allen, Jay Yang, Minji Ko, John Paul SanGiovanni, James D. Akula, Saswata Talukdar, Ann Hellström, Lois E. H. Smith	2022	26
15	A Phase 1b Study of Vadastuximab Talirine in Combination with 7+3 Induction Therapy for Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Blood ·Harry P. Erba, Moshe Levy, Sumithira Vasu, Anthony S. Stein, Amir T. Fathi, Michael B. Maris, Anjali S. Advani, Stefan Faderl, Scott E. Smith, Brent L. Wood, Roland B. Walter, Jay Yang, William B. Donnellan, Eric J. Feldman, Jenna L. Voellinger, Farhad Ravandi	2016	23
16	A phase 1 dose escalation study of the IDH1m inhibitor, FT-2102, in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). Journal of Clinical Oncology ·Justin M. Watts, Maria R. Baer, Sang‐Min Lee, Jay Yang, Shira Dinner, Thomas Prébet, Gary J. Schiller, Karen Seiter, P. Brent Ferrell, Patrick Kelly, Ping Li, Jennifer Sweeney, Courtney Watson, Hesham Mohamed, Jörge E. Cortes	2018	20
17	First‐in‐human study of JNJ‐63709178, a CD123/CD3 targeting antibody, in relapsed/refractory acute myeloid leukemia Clinical and Translational Science ·Michael Boyiadzis, Pinkal Desai, Nikki Daskalakis, William B. Donnellan, Lucille Ferrante, Jeffrey L. Goldberg, Michael R. Grunwald, Christina Guttke, Xiang Li, Josè Antonio Pérez-Simón, Olga Salamero, Trevor Tucker, Xiaoying Xu, Jay Yang, Naveen Pemmaraju, Juan Manuel Alonso‐Domínguez	2022	18
18	E4F1 Is a Master Regulator of CHK1-Mediated Functions Cell Reports ·David Grote, Céline Moison, Stéphanie Duhamel, Jalila Chagraoui, Simon Girard, Jay Yang, Nadine Mayotte, Yan Coulombe, Jean‐Yves Masson, Grant W. Brown, Sylvain Meloche, Guy Sauvageau	2015	17
19	Olutasidenib (FT-2102) Induces Rapid Remissions in Patients with IDH1-Mutant Myelodysplastic Syndrome: Results of Phase 1/2 Single Agent Treatment and Combination with Azacitidine Blood ·Jörge E. Cortes, Eunice S. Wang, Justin M. Watts, Sangmin Lee, Maria R. Baer, Kim‐Hien Dao, Shira Dinner, Jay Yang, William B. Donnellan, Anthony P. Schwarer, Christian Récher, Patrick Kelly, Jennifer Sweeney, Julie Brevard, Patrick Henrick, Sanjeev Forsyth, Sylvie M. Guichard, Hesham Mohamed, Andrew H. Wei	2019	16
20	Update on phase 1 study of tazemetostat, an enhancer of zeste homolog 2 inhibitor, in pediatric patients with relapsed or refractory integrase interactor 1–negative tumors. Journal of Clinical Oncology ·N. Susan, Franck Bourdeaut, Michela Casanova, Lindsay Kilburn, Darren Hargrave, Geoffrey McCowage, Navin Pinto, Jay Yang, Raminder Chadha, Bhaskar Kahali, Coya Tapia, Karsten Nysom	2022	16

About Jay Yang

Jay Yang is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Molecular Biology and Oncology, having authored 103 papers that have together received 1.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (35 papers), Chronic Myeloid Leukemia Treatments (16 papers), Protein Degradation and Inhibitors (13 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers), Lymphoma Diagnosis and Treatment (13 papers), Histone Deacetylase Inhibitors Research (11 papers), Cancer-related gene regulation (11 papers) and DNA Repair Mechanisms (7 papers). The work is most often cited by research in Hematology (318 citations), Molecular Biology (810 citations), Cancer Research (156 citations), Oncology (281 citations) and Genetics (103 citations). Jay Yang has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Grant W. Brown, Ian D. Hickson, Csanád Z. Bachrati, Yongwei Su, Yubin Ge, Holly Edwards, Jeffrey W. Taub, Alexandra Sobeck, Rong Guo and Dongyi Xu. Their work appears in journals such as Blood, Journal of Clinical Oncology, Hematological Oncology, Journal of Pain and Haematologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact